Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Mar 20
Love0

Analysis of Utilization, Cost, and Prescription Trends of Common Immunosuppressive Medications Among Medicare Patients 2013 to 2019

By Chuck Lin No Comments
INTRODUCTIONImmunosuppressive medications are commonly used to manage dermatological conditions, including atopic dermatitis, psoriasis, and bullous diseases. However, cost and adverse effect profile, including increased risk of infections, are important considerations.1…
Read More
Mar 20
Love0

Advancing Dermatology Education and Care in Rwanda: The Impact of a New Academic Partnership

By Chuck Lin No Comments
Dear Editor, This past spring the inaugural class, now fifth-year medical students, at The University of Global Health Equity (UGHE) in Butaro, Rwanda entered their sub-specialty training in Dermatology. UGHE is…
Read More
Mar 18
Love0

Cutaneous Squamous Cell Carcinoma In Situ on a Fingernail Treated With HPV Vaccine

By Chuck Lin No Comments
INTRODUCTIONSquamous cell carcinoma (SCC) is one of the most common malignant neoplasms, and its incidence is increasing.1 Some patients are considered poor candidates for surgery due to the location of…
Read More
Mar 12
Love0

Oral Lichen Planus Successfully Treated With Upadacitinib

By Chuck Lin No Comments
INTRODUCTIONOral lichen planus (OLP) is an inflammatory mucosal disease, mediated by a predominantly T-cell lymphocytic response at the dermoepidermal junction.1 With a global prevalence of approximately 1%, OLP can have…
Read More
Mar 12
Love0

Comparing the Safety and Effectiveness of Microfocused Ultrasound: Standard vs Targeted Tissue Protocol in Lifting and Tightening the Lower Face and Upper Neck

By Chuck Lin No Comments
INTRODUCTIONA well contoured jawline is a key factor in the perception of facial attractiveness and youthfulness in both men and women.1-3 Patients are increasingly interested in non-invasive methods with little…
Read More
Mar 12
Love0

Analysis of Reddit Reveals JAK Inhibitor Questions Among Atopic Dermatitis Patients

By Chuck Lin No Comments
INTRODUCTIONReddit is the 7th most visited site in the United States (US) and has become a popular forum for health-related discussions.1 According to a 2021 study, users ages 10-19 comprise…
Read More
Mar 07
Love0

Molecular Insights Into the Effects of PLLA-SCA on Gene Expression and Collagen Synthesis in Human 3D Skin Models Containing Macrophages

By Chuck Lin No Comments
INTRODUCTIONPoly-l-lactic acid (PLLA-SCA) is a synthetic polymer used as an injectable to restore volume and stimulate collagen formation.1 It was initially approved by the US Food and Drug Administration (FDA)…
Read More
Mar 07
Love0

Mitogen-Activated Protein Kinase Inhibitor-Induced Inflammatory Alopecia in Woman With Ovarian Cancer

By Chuck Lin No Comments
INTRODUCTIONTargeted therapies against the mitogen-activated protein (MAP) kinase pathway, known to contribute to tumorigenesis, have emerged to treat a variety of cancers.1 Mitogen-activated protein kinase kinase (MEK) inhibitors are FDA-approved…
Read More
Mar 07
Love0

Functional and Cutaneous Treatment Outcomes With Intravenous Immunoglobulin for Eosinophilic Fasciitis: A Retrospective Study

By Chuck Lin No Comments
INTRODUCTIONEosinophilic fasciitis (EF) is a rare subtype of deep morphea characterized by progressive symmetric sclerosis of the fascia of the distal extremities with or without truncal involvement.1 Joint contractures, myalgias,…
Read More
Mar 01
Love0

FULL SUPPLEMENT: Prebiotic Skincare Management of Atopic Dermatitis & Xerosis in Diverse Ethnically Patients

By Chuck Lin No Comments
In this supplement: Recent Advances in Skincare Management of Atopic Dermatitis in Diverse Racial and Ethnic Groups Atopic Dermatitis (AD) is a chronic relapsing inflammatory skin disease associated with a…
Read More
Mar 01
Love0

FULL SUPPLEMENT: Real-World Patient Cases Using Botanical Serum-Containing Corrective Gel as an Adjunct to Aesthetic Facial Energy-Based Device Treatments

By Chuck Lin No Comments
In this supplement: Real-World Patient Cases Using Botanical Serum-Containing Corrective Gel as an Adjunct to Aesthetic Facial Laser or Microneedling Radiofrequency (MRF) Treatment Integrated skin care is defined as the complementary…
Read More
Mar 01
Love0

Beyond Wrinkles: A Comprehensive Review of the Uses of Botulinum Toxin

By Chuck Lin No Comments
INTRODUCTIONBotulinum neurotoxin (BoNT) is the most potent neurotoxin in existence.1 BoNT is derived from Clostridium botulinum, a gram positive, anaerobic, spore-forming bacteria.2 C. botulinum produces many subtypes of toxin, denoted…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors May 23, 2025
  • A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis May 22, 2025
  • Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study May 21, 2025
  • JDD in the News: Upadacitinib’s Potential Cardiovascular Effects  May 21, 2025
  • Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares May 20, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search